171 related articles for article (PubMed ID: 35369795)
1. Impact of Antiretroviral Therapy on Kidney Disease in HIV Infected Individuals - A Qualitative Systematic Review.
Adnani H; Agrawal N; Khatri A; Vialet J; Zhang M; Cervia J
J Int Assoc Provid AIDS Care; 2022; 21():23259582221089194. PubMed ID: 35369795
[TBL] [Abstract][Full Text] [Related]
2. Comparison of risk factors and outcomes in HIV immune complex kidney disease and HIV-associated nephropathy.
Foy MC; Estrella MM; Lucas GM; Tahir F; Fine DM; Moore RD; Atta MG
Clin J Am Soc Nephrol; 2013 Sep; 8(9):1524-32. PubMed ID: 23685946
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and outcomes of HIV-associated immune complex kidney disease.
Booth JW; Hamzah L; Jose S; Horsfield C; O'Donnell P; McAdoo S; Kumar EA; Turner-Stokes T; Khatib N; Das P; Naftalin C; Mackie N; Kingdon E; Williams D; Hendry BM; Sabin C; Jones R; Levy J; Hilton R; Connolly J; Post FA;
Nephrol Dial Transplant; 2016 Dec; 31(12):2099-2107. PubMed ID: 26786550
[TBL] [Abstract][Full Text] [Related]
4. Differentiating HIV-associated nephropathy from antiretroviral drug-induced nephropathy: a clinical challenge.
Kumar N; Perazella MA
Curr HIV/AIDS Rep; 2014 Sep; 11(3):202-11. PubMed ID: 24924830
[TBL] [Abstract][Full Text] [Related]
5. Glomerular diseases related to HIV in Colombian population: Better outcomes with highly active antiretroviral therapy?
Muñoz-Velandia O; García-Peña Á; Garzón-Herazo J; Contreras-Villamizar K; Rodríguez-Sánchez M; Garcia-Consuegra E; Toro-Trujillo E
J Infect Dev Ctries; 2020 Sep; 14(9):1027-1032. PubMed ID: 33031092
[TBL] [Abstract][Full Text] [Related]
6. [Kidney disease in HIV-infected patient].
Matuszkiewicz-Rowińska J; Wieliczko M
Wiad Lek; 2016; 69(5):725-728. PubMed ID: 28033595
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapeutic options for kidney disease in HIV positive patients.
Tariq A; Kim H; Abbas H; Lucas GM; Atta MG
Expert Opin Pharmacother; 2021 Jan; 22(1):69-82. PubMed ID: 32955946
[TBL] [Abstract][Full Text] [Related]
8. Interventions for HIV-associated nephropathy.
Yahaya I; Uthman OA; Uthman MM
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD007183. PubMed ID: 23440812
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy and treatment options for HIV-associated nephropathy.
Menez S; Hanouneh M; McMahon BA; Fine DM; Atta MG
Expert Opin Pharmacother; 2018 Jan; 19(1):39-48. PubMed ID: 29224373
[TBL] [Abstract][Full Text] [Related]
10. HIV and kidney: a dangerous liaison.
Bertoldi A; De Crignis E; Miserocchi A; Bon I; Musumeci G; Longo S; D'Urbano V; La Manna G; Calza L; Re MC
New Microbiol; 2017 Jan; 40(1):1-10. PubMed ID: 28217815
[TBL] [Abstract][Full Text] [Related]
11. HIV-associated kidney glomerular diseases: changes with time and HAART.
Lescure FX; Flateau C; Pacanowski J; Brocheriou I; Rondeau E; Girard PM; Ronco P; Pialoux G; Plaisier E
Nephrol Dial Transplant; 2012 Jun; 27(6):2349-55. PubMed ID: 22248510
[TBL] [Abstract][Full Text] [Related]
12. Kidney and liver organ transplantation in persons with human immunodeficiency virus: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(4):1-56. PubMed ID: 23074407
[TBL] [Abstract][Full Text] [Related]
13. A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa.
Han TM; Naicker S; Ramdial PK; Assounga AG
Kidney Int; 2006 Jun; 69(12):2243-50. PubMed ID: 16672914
[TBL] [Abstract][Full Text] [Related]
14. Renal disease in HIV-infected individuals.
Phair J; Palella F
Curr Opin HIV AIDS; 2011 Jul; 6(4):285-9. PubMed ID: 21519246
[TBL] [Abstract][Full Text] [Related]
15. Reduced renal function is associated with progression to AIDS but not with overall mortality in HIV-infected Kenyan adults not initially requiring combination antiretroviral therapy.
Gupta SK; Ong'or WO; Shen C; Musick B; Goldman M; Wools-Kaloustian K
J Int AIDS Soc; 2011 Jun; 14():31. PubMed ID: 21663693
[TBL] [Abstract][Full Text] [Related]
16. HIVAN and medication use in chronic dialysis patients in the United States: analysis of the USRDS DMMS Wave 2 study.
Abbott KC; Trespalacios FC; Agodoa LY; Ahuja TS
BMC Nephrol; 2003 Jul; 4():5. PubMed ID: 12837135
[TBL] [Abstract][Full Text] [Related]
17. A review of renal disease in children with HIV infection.
Jindal AK; Tiewsoh K; Pilania RK
Infect Dis (Lond); 2018 Jan; 50(1):1-12. PubMed ID: 28885079
[TBL] [Abstract][Full Text] [Related]
18. Interventions for HIV-associated nephropathy.
Yahaya I; Uthman AO; Uthman MM
Cochrane Database Syst Rev; 2009 Oct; (4):CD007183. PubMed ID: 19821397
[TBL] [Abstract][Full Text] [Related]
19. Treatment of HIV-associated nephropathy.
Winston JA; Burns GC; Klotman PE
Semin Nephrol; 2000 May; 20(3):293-8. PubMed ID: 10855939
[TBL] [Abstract][Full Text] [Related]
20. Absence of APOL1 risk variants protects against HIV-associated nephropathy in the Ethiopian population.
Behar DM; Kedem E; Rosset S; Haileselassie Y; Tzur S; Kra-Oz Z; Wasser WG; Shenhar Y; Shahar E; Hassoun G; Maor C; Wolday D; Pollack S; Skorecki K
Am J Nephrol; 2011; 34(5):452-9. PubMed ID: 21968148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
